LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

Search

Assertio Holdings Inc

Ouvert

0.65 -1.52

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.64

Max

0.66

Chiffres clés

By Trading Economics

Revenu

-3.1M

-14M

Ventes

-5.7M

26M

BPA

-0.04

Marge bénéficiaire

-51.121

Employés

58

EBITDA

-10M

-13M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+324.24% upside

Dividendes

By Dow Jones

Prochains Résultats

6 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.6M

61M

Ouverture précédente

2.17

Clôture précédente

0.65

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Assertio Holdings Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 juin 2025, 17:32 UTC

Principaux Mouvements du Marché

Lion Group Shares Climb on $600 Million Loan for Crypto Treasury

18 juin 2025, 23:55 UTC

Acquisitions, Fusions, Rachats

Nippon Steel: To Book Restructuring Loss Related to This Sale in 1Q

18 juin 2025, 23:53 UTC

Acquisitions, Fusions, Rachats

Nippon Steel: NS Kote Is an Entity That Owns All of Company's Equity Stake in AM/NS Calvert

18 juin 2025, 23:50 UTC

Acquisitions, Fusions, Rachats

Nippon Steel: To Book About Y230B Loss Related to Sale of NS Kote to ArcelorMittal

18 juin 2025, 23:50 UTC

Market Talk

Australian Uranium Stocks Tipped to Go Higher -- Market Talk

18 juin 2025, 23:43 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

18 juin 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18 juin 2025, 23:43 UTC

Market Talk

Nikkei May Decline Amid Middle East Uncertainty -- Market Talk

18 juin 2025, 23:07 UTC

Market Talk

Fletcher Building Recovery May Be More Muted Than Thought -- Market Talk

18 juin 2025, 23:00 UTC

Market Talk

Smart Glasses Seen as Possible Future Agentic AI Platform -- Market Talk

18 juin 2025, 21:50 UTC

Market Talk

Argentina Poised To Become Significant LNG Exporter, Rystad Says -- Market Talk

18 juin 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

18 juin 2025, 20:38 UTC

Acquisitions, Fusions, Rachats

U.S. Steel and Nippon Finalize Their 'Partnership.' What Comes After the Merger. -- Barrons.com

18 juin 2025, 20:32 UTC

Résultats

These Stocks Moved the Most Today: Tesla, Marvell, Sunrun, Nucor, Circle Internet, Korn Ferry, GMS, and More -- Barrons.com

18 juin 2025, 19:59 UTC

Market Talk

Oil Edges Up as Next Steps in Iran Conflict Eyed -- Market Talk

18 juin 2025, 19:42 UTC

Market Talk

Natural Gas Extends Gains for Fourth Session -- Market Talk

18 juin 2025, 19:40 UTC

Résultats

Fed Holds Rates Steady and Keeps Door Open to Cuts -- 3rd Update

18 juin 2025, 18:47 UTC

Acquisitions, Fusions, Rachats

Railroads Have Slashed Costs and Raised Prices. Why One CEO Now Favors a Merger. -- Barrons.com

18 juin 2025, 18:33 UTC

Market Talk

Fitch Says U.S. Fiscal Outlook Remains Challenging -- Market Talk

18 juin 2025, 18:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18 juin 2025, 18:26 UTC

Market Talk

Nucor, Steel Dynamics Seen Diverging In Approach To Current Business Climate -- Market Talk

18 juin 2025, 18:15 UTC

Market Talk

Gold Stays Flat After Fed Decision -- Market Talk

18 juin 2025, 17:42 UTC

Acquisitions, Fusions, Rachats

ArcelorMittal Expects Related 2Q Gain of About $1.5B

18 juin 2025, 17:40 UTC

Acquisitions, Fusions, Rachats

ArcelorMittal Completes Acquisition of Nippon Steel's 50% Interest in AM/NS Calvert

18 juin 2025, 17:20 UTC

Résultats

Credit Card Annual Fees Are Going Up. What It Means for the Stocks. -- Barrons.com

18 juin 2025, 16:52 UTC

Market Talk

Trump Awakens Canada On Need For Fewer Trade Barriers, Macklem Says -- Market Talk

18 juin 2025, 16:31 UTC

Acquisitions, Fusions, Rachats

Nippon Steel Completes Purchase of U.S. Steel After Reaching Security Deal With Trump Administration -- Update

18 juin 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 juin 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 juin 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparaison

Variation de prix

Assertio Holdings Inc prévision

Objectif de Prix

By TipRanks

324.24% hausse

Prévisions sur 12 Mois

Moyen 2.8 USD  324.24%

Haut 3.5 USD

Bas 1.5 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

4

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

0.618 / 0.649Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.